CI

At a glance

ClinicalIndex Comparison Record
Phase 1Completed· 69 enrolled
Drug / intervention
Apixabandrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02101112
NCT02101112Phase 1Completed
CompareCT.gov

Relative Bioavailability of Crushed Apixaban Tablets Administered With Water or Apple Sauce Compared With Intact Tablet in Healthy Subjects

Bristol-Myers Squibb·interventional·Posted Apr 1, 2014·Updated Mar 3, 2016

In Brief

A Phase 1 clinical trial evaluating Apixaban for Thrombosis. Completed, enrolled 69 participants.

Detailed Summary

The purpose of this study is to determine whether the bioavailability of apixaban crushed tablets suspended in water or mixed with applesauce is similar to the bioavailability of apixaban whole tablets administered orally.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsThrombosis
Countries--
Collaborators--

Timeline

Phase 1CompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedApr 1, 2014
Enrollment StartMar 1, 2014
Primary CompletionMay 1, 2014
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 12.3 years ago

Interventions

Apixabandrug